COVID-19 INFORMATION AND RESOURCES
FOUR WAYS TO REMAIN VIGILANT ABOUT COVID-19
Perspectives on COVID-19 from Mace Rothenberg, M.D.
PARTNERING WITH DIRECT RELIEF TO PROVIDE COVID-19 SUPPLIES TO HOSPITALS
Age: Addressing a Blind Spot in Cancer Care
Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide contract manufacturing services at Pfizer’s McPherson, Kansas facility to manufacture and supply remdesivir for Gilead. In March, Pfizer…